Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M439Revenue $M8.0Net Margin (%)-516.7Z-Score-6.5
Enterprise Value $M390EPS $-0.7Operating Margin %-451.5F-Score4
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-331.0Higher ROA y-yN
Price/Book27.810-y EBITDA Growth Rate %-41.4Quick Ratio1.5Cash flow > EarningsY
Price/Sales50.65-y EBITDA Growth Rate %-29.4Current Ratio1.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-68.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-259.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M60.2ROI % (ttm)-267.8Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSJean-Marie Eveillard 2013-09-30 Buy $4.55 - $6.05
($5.08)
$ 7.242%New holding, 200000 sh.200,000
SNSSJean-Marie Eveillard 2013-03-31 Sold Out -0.01%$4 - $6.49
($5.21)
$ 7.238%Sold Out0
SNSSJean-Marie Eveillard 2012-09-30 Reduce$2.95 - $5.76
($3.55)
$ 7.2103%Reduce -30.24%350,000
SNSSJean-Marie Eveillard 2012-06-30 Buy 0.01%$2.51 - $3.18
($2.78)
$ 7.2159%New holding, 501727 sh.501,727
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SNSS Jean-Marie Eveillard 2014-06-30200,0000.330-8.91%
Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BARRIS PETER J10% Owner 2014-08-29Sell266,700$7.97-10.29view
BARRETT M JAMES10% Owner 2014-08-29Sell266,700$7.97-10.29view
Growth Equity Opportunities Fu10% Owner 2014-08-29Sell266,700$7.97-10.29view
SANDELL SCOTT D10% Owner 2014-08-29Sell266,700$7.97-10.29view
KOLLURI KRISHNA KITTU10% Owner 2014-08-29Sell266,700$7.97-10.29view
KERINS PATRICK J10% Owner 2014-08-29Sell266,700$7.97-10.29view
DRANT RYAN D10% Owner 2014-08-29Sell266,700$7.97-10.29view
BASKETT FOREST10% Owner 2014-08-29Sell266,700$7.97-10.29view
Misfeldt DaytonDirector, 10% Owner 2014-08-28Sell300,700$7.98-10.4view
BAY CITY CAPITAL LLC10% Owner 2014-08-28Sell300,700$7.98-10.4view

Press Releases about SNSS :

    Quarterly/Annual Reports about SNSS:

    News about SNSS:

    Articles On GuruFocus.com
    comment on SNSS Mar 02 2013 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
    Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
    cooldecency99 note on SNSS May 01 2010 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
    Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
    Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
    Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 
    Sunesis Reports Financial Results for the Second Quarter 2009 Jul 29 2009 

    More From Other Websites
    Sunesis to Present at the 2014 Morgan Stanley Global Healthcare Conference Sep 04 2014
    Sunesis Takes a Run Through the Feuerstein-Ratain Rule Sep 02 2014
    Sunesis Pharmaceuticals (SNSS) in Focus: Stock Rises 9.9% Aug 28 2014
    UBS Says Sunesis Leukemia Pivotal Trial Success 'Likely' Aug 27 2014
    Weak On High Volume: Sunesis Pharmaceuticals (SNSS) Aug 26 2014
    Your September Biotech Back-to-School Calendar Aug 26 2014
    SUNESIS PHARMACEUTICALS INC Financials Aug 15 2014
    Sunesis Pharmaceuticals, Inc. (SNSS) Jumps: Stock Rises 9% Aug 06 2014
    Sunesis to Present at the 2014 Wedbush Life Sciences Management Access Conference Aug 06 2014
    Sunesis Pharmaceuticals Inc Earnings Call scheduled for 11:00 am ET today Aug 05 2014
    SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 05 2014
    Q2 2014 Sunesis Pharmaceuticals, Inc. Earnings Release - Before Market Open Aug 05 2014
    Sunesis Pharmaceuticals Reports Second Quarter 2014 Financial Results and Recent Highlights Aug 05 2014
    Sunesis to Host Conference Call on August 5th to Discuss Second Quarter 2014 Financial Results and... Jul 29 2014
    Sunesis' Pediatric Plan Accepted in the EU Jul 14 2014
    Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation... Jul 09 2014
    Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation... Jul 09 2014
    Sunesis Pharmaceuticals (SNSS) Soars: Stock Adds 8% in Session Jun 13 2014
    SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 09 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK